What is Apremilast? Drug ingredients, functions and usage background

Apremilast is an oral small molecule drug that is a phosphodiesterase 4 (PDE4) inhibitor. It achieves anti-inflammatory and immunomodulatory effects by regulating the production of inflammatory mediators in the immune system. Apremilast is mainly used to treat a variety of inflammatory diseases, especially in the management of autoimmune diseases such as psoriasis and psoriatic arthritis. Its unique mechanism of action makes it a non-biologic treatment option.

The active ingredient of apremilast isapremilast, which is a molecule that selectively inhibits phosphodiesterase 4. By inhibiting PDE4, apremilast can increase intracellular cyclic adenosine monophosphate (cAMP) levels, thereby regulating the function of inflammatory cells and reducing pro-inflammatory cytokines such as tumor necrosis factor (TNF-α), interleukin-17 (IL-17) and interleukin-23 (IL-23). This mechanism helps relieve inflammation, reduce patients' symptoms, and improve their quality of life.

Apremilast is primarily indicated for the treatment of patients with moderate to severe plaque psoriasis and psoriatic arthritis. Compared with traditional immunosuppressants, Apremilast's oral administration method is more convenient and is not a biological agent, avoiding the discomfort and risks associated with injections. In addition, Apremilast has a mild effect on patients' immune systems and is highly safe, making it suitable for use by some patients who are not suitable for biologic treatment.

In clinical use, the dose of Apremilast usually needs to be gradually adjusted according to the guidance of a doctor to reduce the incidence of side effects. Common adverse reactions include diarrhea, nausea, headache, etc. Patients should pay attention to their own conditions during medication and communicate with their doctors in a timely manner. Overall, apremilast, as a new type of immunomodulatory drug, provides more treatment options for patients with inflammatory diseases, especially in patients who require long-term maintenance treatment, showing good tolerability and efficacy.

Reference materials:https://go.drugbank.com/drugs/DB05676